Short answer: Supriya Ganesh is leaving The Pitt after its second season, with her final appearance in that season’s finale.
Overview
- Who she is: Supriya Ganesh, who plays Dr. Samira Mohan on The Pitt, HBO Max’s medical drama set at a Pittsburgh teaching hospital. This is supported by multiple outlets reporting her exit at the end of season 2.[1][4]
- Timing of exit: Her departure is tied to the end of season 2, with reports confirming she won’t be back for Season 3 and that her final appearance would be in the season 2 finale (airing mid-April 2026).[4][8][1]
- Official framing: Variety and other outlets describe the decision as “story-driven,” reflecting typical staff turnover in a teaching hospital drama where characters come and go as plots progress.[7][1]
- Reactions and context: The news sparked fan discussion and coverage about cast changes, with publishers noting shifts in the ensemble and promotions of other cast members (e.g., a character promoted to series regular) in response to the exit.[8][4]
- How this is being handled on air: Creators and producers have acknowledged the departure, framing it within realistic ER turnover and indicating ongoing development of new cast members to fill the narrative space.[7][8]
What this means for viewers
- If you’re following The Pitt, expect Dr. Mohan to appear in the Season 2 finale as her last episode, and anticipate new cast members or shifts in the hospital staff dynamic in Season 3.[1][4]
- Public reactions have been mixed, with some fans expressing disappointment, while others point to the show’s commitment to realistic turnover as a storytelling device.[9][7]
Illustrative note
- For a quick sense of the timeline: reports surfaced early April 2026 confirming Ganesh’s exit, with outlets like E! News and BuzzFeed publishing details, and Variety providing the authoritative framing around the departure as story-driven.[4][1][7]
Citations
- The Pitt exit details and timing:,,.[1][4][7]
- Context on casting shifts and season 3 planning:,.[8][9]
- Audience reaction and industry commentary:,.[7]